Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | HLCS | P50747 | 1/20 | 0.38 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | PRKCA | P17252 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL735231 | 1.00 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1CYP19A1NPC1KMT2A | |
| SCHEMBL8697031 | 1.00 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1CYP19A1NPC1KMT2A | |
| SCHEMBL734158 | 1.00 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1CYP19A1NPC1KMT2A | |
| SCHEMBL18626078 | 1.00 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1CYP19A1NPC1KMT2A | |
| SCHEMBL3372427 | 1.00 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1CYP19A1NPC1KMT2A | |
| SCHEMBL734754 | 1.00 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1CYP19A1NPC1KMT2A | |
| SCHEMBL11727127 | 1.00 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1CYP19A1NPC1KMT2A | |
| SCHEMBL6536968 | 1.00 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1CYP19A1NPC1KMT2A | |
| SCHEMBL5617175 | 1.00 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1CYP19A1NPC1KMT2A | |
| SCHEMBL7643509 | 1.00 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1CYP19A1NPC1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4607319-B2 | — | — | 2011-01-05 | — | — | JP | claimed |
| JP-2002512190-A | — | — | 2002-04-23 | — | — | JP | claimed |
| EP-1079832-A1 | USE OF VITAMIN PP COMPOUNDS | Klinge Pharma GmbH (DE) | 2001-03-07 | — | — | EP | claimed |
| EP-1042315-A1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | Klinge Pharma GmbH (DE) | 2000-10-11 | — | — | EP | claimed |
| WO-1999053920-A1 | USE OF VITAMIN PP COMPOUNDS | KLINGE PHARMA GMBH (DE) | 1999-10-28 | — | — | WO | claimed |
| WO-1999031087-A1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE PHARMA GMBH (DE) | 1999-06-24 | — | — | WO | claimed |
| WO-2023288226-A2 | POLYMER ENGINEERED FORMS OF INTERFERON-GAMMA AND METHODS OF USE | NEKTAR THERAPEUTICS (US) | 2023-01-19 | — | — | WO | disclosed |
| US-20180134717-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | SPIROGEN LIMITED (GB) | 2018-05-17 | — | — | US | disclosed |
| US-9649390-B2 | Pyrrolobenzodiazepines and conjugates thereof | MEDIMMUNE LIMITED (GB) | 2017-05-16 | — | — | US | disclosed |
| CN-104031140-B | Truncated analogues of glucose-dependent insulinotropic polypeptide | 益普生制药股份有限公司 | 2017-04-12 | — | — | CN | disclosed |
| US-9567340-B2 | Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases | MEDIMMUNE LIMITED (GB) | 2017-02-14 | — | — | US | disclosed |
| EP-2915538-A2 | Truncated analogues of glucose-dependent insulinotropic polypeptide | IPSEN PHARMA S.A.S. (FR) | 2015-09-09 | — | — | EP | disclosed |
| EP-2320923-B1 | TRUNCATED ANALOGUES OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE | IPSEN PHARMA SAS (FR) | 2014-12-24 | — | — | EP | disclosed |
| CN-1102601-C | Unsaturated copolymer based on olefin and production and use thereof | MITSUI PETROCHEMICAL IND (JP) | 2003-03-05 | — | — | CN | disclosed |
| CN-1344283-A | Ethylene copolymer rubber, process for producing the same, and use thereof | MITSUI CHEMICALS INC (JP) | 2002-04-10 | — | — | CN | disclosed |
| EP-1079832-A1 | USE OF VITAMIN PP COMPOUNDS | Klinge Pharma GmbH (DE) | 2001-03-07 | — | — | EP | disclosed |
| EP-1042315-A1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | Klinge Pharma GmbH (DE) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999053920-A1 | USE OF VITAMIN PP COMPOUNDS | KLINGE PHARMA GMBH (DE) | 1999-10-28 | — | — | WO | disclosed |
| WO-1999031087-A1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE PHARMA GMBH (DE) | 1999-06-24 | — | — | WO | disclosed |
| CN-1166501-A | Unsaturated copolymer based on olefin and production and use thereof | MITSUI PETROCHEMICAL IND (JP) | 1997-12-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134717-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | HDAC10, PBDC1, PDCD10 | ALDH1A1 1192/4885L3MBTL1 243/4885CYP19A1 2034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.